Villepinte, March 13, 2017 - Guerbet takes note of the recommendations issued by the Pharmacovigilance Risk Assessment Committee (PRAC), on Gadolinium-based Contrast Agents - procedure under Article 31 of Directive 2001/83/EC.
02/27/2017 ECR 2017: Guerbet will be there!
ECR 2017 | Expo Hall X2 – Booth 21 | from March 1 to 5 | Austria Center Vienna ӏ Vienna (Austria)
02/16/2017 Explore 90 years of passion on guerbet90.com
As part of the “90 Years of Passion” campaign, Guerbet is launching a website, guerbet90.com, on the birth date of its founder, André Guerbet.
Objective of a sales turnaround after the CMDS acquisition achieved. Growth in revenue in the fourth quarter for all activities and all geographic regions.